RT Journal Article
SR Electronic
T1 COVID-19 Wastewater Epidemiology: A Model to Estimate Infected Populations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.11.05.20226738
DO 10.1101/2020.11.05.20226738
A1 Christopher Steven McMahan
A1 Stella Self
A1 Lior Rennert
A1 Corey Kalbaugh
A1 David Kriebel
A1 Duane Graves
A1 Jessica A. Deaver
A1 Sudeep Popat
A1 Tanju Karanfil
A1 David L. Freedman
YR 2020
UL http://medrxiv.org/content/early/2020/11/07/2020.11.05.20226738.abstract
AB BACKGROUND Wastewater-based epidemiology (WBE) provides an opportunity for near real-time, cost-effective monitoring of community level transmission of SARS-CoV-2, the virus that causes COVID-19. Detection of SARS-CoV-2 RNA in wastewater can identify the presence of COVID-19 in the community, but methods are lacking for estimating the numbers of infected individuals based on wastewater RNA concentrations.METHODS Composite wastewater samples were collected from three sewersheds and tested for SARS-CoV-2 RNA. A Susceptible-Exposed-Infectious-Removed (SEIR) model based on mass rate of SARS-CoV-2 RNA in the wastewater was developed to predict the number of infected individuals. Predictions were compared to confirmed cases identified by the South Carolina Department of Health and Environmental Control for the same time period and geographic area.RESULTS Model predictions for the relationship between mass rate of virus release to the sewersheds and numbers of infected individuals were validated based on estimated prevalence from individual testing. A simplified equation to estimate the number of infected individuals fell within the 95% confidence limits of the model. The unreported rate for COVID-19 estimated by the model was approximately 12 times that of confirmed cases. This aligned well with an independent estimate for the state of South Carolina.CONCLUSIONS The SEIR model provides a robust method to estimate the total number of infected individuals in a sewershed based on the mass rate of RNA copies released per day. This overcomes some of the limitations associated with individual testing campaigns and thereby provides an additional tool that can be used to better inform policy decisions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding provided by Clemson University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used is publicly available and can be found in the links below. https://scdhec.gov/covid19/sc-testing-data-projections-covid-19 https://www.clemson.edu/covid-19/testing/wastewater-dashboard.html